NovaBay Pharmaceuticals, Inc. ( NBY) - Stock Earnings
Stock symbol NBY is outdated, potentially delisted? Maybe it is available on other exchange?
Ticker NBY was renamed to
SDEV
effective 2026-04-06.
NBY Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q2 | -1.9 million USD | — USD |
| 2025Q3 | -1.3 million USD | 521000 USD |
| 2025Q4 | -26.6 million USD | -521000 USD |
| 2026Q2 Est. | — | — |
| 2026Q3 Est. | — | — |
NBY Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -9.6 million USD | 10.5 million USD |
| 2024 | -7.2 million USD | 9.8 million USD |
| 2025 | -22.1 million USD | — USD |
| 2026 Est. | — | — |
NBY
Price: $1.88
52 week price:
Earnings Per Share: -28.50 USD
Exchange: ASE
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 100900
Market Capitalization: 51.9 million